A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study-Reference-Cited by-同舟云学术

A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study

Published:2019-09 Issue:9 Volume:45 Page:1644-1651
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Zhang Xiu-Ping,Chen Zhen-Hua,Zhou Teng-Fei,Li Le-Qun,Chen Min-Shan,Wen Tian-Fu,Shi Jie,Guo Wei-Xing,Wu Meng-Chao,Lau Wan Yee,Cheng Shu-Qun

Funder

National Key Basic Research Programme “973 project”

Natural Science Foundation of China

Shanghai Municipal Health Bureau

Shanghai Science and Technology Committee

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference44 articles.

1. Global cancer statistics;Torre;CA: a cancer journal for clinicians,2012

2. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma;Bruix;Gastroenterology,2016

3. Hepatocellular carcinoma;Forner;Lancet,2012

4. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases;Marrero,2018

5. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study;Zhang,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding Indications for Surgical Resection in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

2. PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review;Frontiers in Oncology;2023-10-05

3. A contrast-enhanced ultrasound-based nomogram for the prediction of therapeutic efficiency of anti-PD-1 plus anti-VEGF agents in advanced hepatocellular carcinoma patients;Frontiers in Immunology;2023-07-27

4. Postoperative adjuvant tyrosine kinase inhibitors combined with anti-PD-1 antibodies improves surgical outcomes for hepatocellular carcinoma with high-risk recurrent factors;Frontiers in Immunology;2023-06-08

5. A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection;Frontiers in Oncology;2023-03-17